The 3rd Annual Genome Editing & Engineering Conference taking place on 8th - 9th February 2018 in San Diego, USA aims at bringing together the key industry leaders, experts and researchers to address the most recent case studies and research on functional genome screening and precision gene editing to reveal their potential applications.
By attending this event, you’ll participate in the most exciting and challenging discussions on the industry’s most difficult applications including viral gene vectors and vaccines, adeno-associated virus (AAV), and other products derived with baculovirus technology, plus cellular therapies and three-dimensional, cellular structures. You can attend any talk you choose from the three concurrent programs, plus you’ll participate in a number of fun and stimulating networking events throughout the meeting that you can attend at no additional cost. This meeting offers unique opportunities to share technology with some of the most talented people in the biotech industry, plus key regulators and essential supply firms.
The dvanced herapies ummit s ulti-stakeholder, nteractive orum hat eeks o xchange iews nd ake ecommendations n ow est o dvance he TMP ector n urope. he onference rings ogether he op xecutives, linical esearchers, ublic olicy akers nd ther embers f he dvanced herapies ommunity o ighlight he ajor chievements s ell s he ain hallenges xperienced long he ath rom iscovery o elivery f ransformative – nd ven otentially urative – herapies. his ear’s rogram ill eature nteractive oundtable iscussions nd etworking pportunities.
Cell and Gene Therapy Conference is to ameliorate the knowledge, awareness, and education on cell and gene therapy leading to the discovery of genetic and cellular therapies which aid to alleviate the human disease as it is the most significant emerging technology in the eyes of Medical, Biotechnology, Pharmaceuticals and Academia. Cell and Gene Therapy Conference 2018 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
Back for its 11th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2018 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in the different therapeutic sectors. The Forum also features keynote speeches by KOL, about 70 selected corporate presentations from established (public and private) and emerging biotechs seeking to promote investment and partnering opportunities. There is also a focus on early stage innovation and an elevator session with 20 companies.
The Stem Cell Summit provides information on cutting-edge developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. This summit comprises of presentations, panels and round-table discussions to highlight pre-clinical and clinical studies in regenerative medicine, immunotherapy, stem cell reprogramming, cell therapy in diabetes, regulatory policies regarding stem cell research, manufacturing and other relevant topics.
Cell & Gene Therapy Meeting 2018 will be organized around the theme “An insight into Cell & Gene Therapy for sound lives”. This Global Meet will bring together world-class personalities working on cell and gene therapy, stem cells, tissue engineering and regenerative medicine to discuss about the Frontiers in Cell and Gene Therapy: From Bench to Bedside.
Lentviral and retroviral vectors are at the forefront of advanced therapeutic medicinal product (ATMP) development. This one-day conference aims to give attendees an overview about the successes, challenges and areas for future development. Key national and international speakers including Adrian Thrasher and Luigi Naldini have accepted the invitation to speak at the conference.
Gene Therapy for Rare Disorders 2018 will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Incorporating insights from Spark, Bluebird Bio, Pfizer and GSK, this unique conference will delve into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.
ASGCT’s 21st Annual Meeting will take place May 16-19, at the Hilton Chicago. Attendee registration opens on December 1 and room reservations in ASGCT’s room block will be released shortly thereafter.
International Conference on Stem Cells & Regenerative Medicine - Genome Editing for Targeting Genetic Diseases
Allied Academies invites all the participants from all across the globe to attend "International Conference on Stem Cells and Regenerative Medicine”, on June 18-19, 2018 in Osaka, Japan, which includes prompt keynote presentations, poster presentations, oral talks, and exhibitions.
Annual Congress on Advanced Tissue Science and Regenerative Medicine is delighted to welcome all the interested and enthusiastic participants across the globe with the theme “Discover the Advancements in Tissue Science and Regenerative Medicine” Which includes prompt keynote presentations, Oral talks, productive Poster presentations and Exhibitions providing insights to the importance and Developments in Tissue Science and Regenerative medicine.
The Gene Therapy Bioproduction Conference will bring together leading scientists, clinicians, executives and experts who can collectively disperse information on the impact of recent findings on gene therapy and how it can be applied. This conference will highlight scientific breakthroughs, use of innovative technologies and approaches to tackle gene delivery and the translational challenges, and bring together the right people to discuss existing challenges and future opportunities in this field.
At the Winter 2018 Summit, attendees will explore the theme of "accelerating the commercialization of engineered tissues" through three lenses: optimizing regulatory pathways, enabling workforce readiness and development and securing direct sources of government funding.
The NIH and FDA will be hosting a Regenerative Medicine Innovation Workshop at the Bethesda North Marriott & Convention Center. The purpose of the workshop is to explore the state of regenerative medicine science involving adult stem cells with a focus on approaches to the development of safe and effective products.
The TERMIS-AM Meeting is the key annual meeting held in the Americas each year, and brings together researchers, scientists, trainees, and students from both academia and industry to discuss critical developments in the field. The meeting is led by keynote speakers each day, and consists of parallel technical sessions as well as poster presentations.
This meeting will bring together experts from industry and academia to discuss topics related to the research, technology development, and product commercialization that will be foundational in creating an advanced biomanufacturing industry for the United States.